Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2025-12-28 @ 6:48 AM
Study NCT ID:
NCT00310895
Status:
COMPLETED
Last Update Posted:
2015-12-24
First Post:
2006-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies
Sponsor:
Geron Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03
Start Date Type:
None
Primary Completion Date:
2013-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-04
First Submit QC Date:
None
Study First Post Date:
2006-04-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-12-22
Last Update Post Date:
2015-12-24
Last Update Post Date Type:
ESTIMATED